Posterior reversible encephalopathy syndrome (PRES) is a clinicoradiologic entity characterized by headaches, altered mental status, seizures, visual loss, and characteristic imaging pattern in brain MRI. The cause of PRES is not yet understood. We report a case of a 27-year-old woman that developed PRES after the use of FOLFOX 5 (oxaliplatin/5-Fluoracil/Leucovorin) chemotherapy for a colorectal cancer.
Porcello Marrone, L. C., Marrone, B. F., Pascoal, T. A., Schilling, L. P., Soder, R. B., Ferreira, S. S., … da Costa, J. C. (2013). Posterior Reversible Encephalopathy Syndrome Associated with FOLFOX Chemotherapy. Case Reports in Oncological Medicine, 2013, 1–3. https://doi.org/10.1155/2013/306983